This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Sep 6;372(9641):803-4; author reply 804-5.

doi: 10.1016/S0140-6736(08)61331-8.

Abacavir and increased risk of myocardial infarction

Miguel Goicoechea, Allen McCutchan

PMID: 18774413
DOI: 10.1016/S0140-6736(08)61331-8

Comment

Abacavir and increased risk of myocardial infarction

Miguel Goicoechea et al. Lancet. 2008.

. 2008 Sep 6;372(9641):803-4; author reply 804-5.

doi: 10.1016/S0140-6736(08)61331-8.

Authors

Miguel Goicoechea, Allen McCutchan

PMID: 18774413
DOI: 10.1016/S0140-6736(08)61331-8

No abstract available

PubMed Disclaimer

Comment on

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
D:A:D Study Group; Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. D:A:D Study Group, et al. Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387667 Free PMC article.

Similar articles

Heart attack risk with abacavir and didanosine.
[No authors listed] [No authors listed] AIDS Patient Care STDS. 2008 Apr;22(4):346-7. AIDS Patient Care STDS. 2008. PMID: 18434947 No abstract available.
Abacavir and the potential risk of myocardial infarction.
Cutrell A, Brothers C, Yeo J, Hernandez J, Lapierre D. Cutrell A, et al. Lancet. 2008 Apr 26;371(9622):1413. doi: 10.1016/S0140-6736(08)60492-4. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387668 No abstract available.
FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
[No authors listed] [No authors listed] AIDS Alert. 2008 May;23(5):58-9. AIDS Alert. 2008. PMID: 18642404 No abstract available.
Abacavir and cardiovascular risk.
Behrens GM, Reiss P. Behrens GM, et al. Curr Opin Infect Dis. 2010 Feb;23(1):9-14. doi: 10.1097/QCO.0b013e328334fe84. Curr Opin Infect Dis. 2010. PMID: 19996748 Review.
A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
Wolbach J, Capoccia K. Wolbach J, et al. Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Nurse Pract. 1999. PMID: 10431297 Review. No abstract available.

See all similar articles

Cited by

Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.
Cachay ER, Peterson MR, Goicoechea M, Mathews WC. Cachay ER, et al. Br J Med Med Res. 2011;1(4):346-355. doi: 10.9734/bjmmr/2011/554. Br J Med Med Res. 2011. PMID: 22268001 Free PMC article.
Relaxation effect of abacavir on rat basilar arteries.
Li RW, Yang C, Chan SW, Hoi MP, Lee SM, Kwan YW, Leung GP. Li RW, et al. PLoS One. 2015 Apr 8;10(4):e0123043. doi: 10.1371/journal.pone.0123043. eCollection 2015. PLoS One. 2015. PMID: 25853881 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information